BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15734731)

  • 1. Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells.
    Tripathi MK; Misra S; Khedkar SV; Hamilton N; Irvin-Wilson C; Sharan C; Sealy L; Chaudhuri G
    J Biol Chem; 2005 Apr; 280(17):17163-71. PubMed ID: 15734731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the redox/miR-6855-3p/PRDX5A axis in reversing SLUG-mediated BRCA2 silencing in breast cancer cells.
    Ellison M; Mittal M; Chaudhuri M; Chaudhuri G; Misra S
    Cell Commun Signal; 2020 Jan; 18(1):15. PubMed ID: 31987042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells.
    Mittal MK; Myers JN; Misra S; Bailey CK; Chaudhuri G
    Biochem Biophys Res Commun; 2008 Jul; 372(1):30-4. PubMed ID: 18485278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.
    Misra S; Sharma S; Agarwal A; Khedkar SV; Tripathi MK; Mittal MK; Chaudhuri G
    Mol Cancer; 2010 Mar; 9():50. PubMed ID: 20202217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter.
    Wang J; Bian C; Li J; Couch FJ; Wu K; Zhao RC
    J Biol Chem; 2008 Dec; 283(52):36249-56. PubMed ID: 18990703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of the expressions of cytokeratins 8 and 19 by SLUG repressor protein in human breast cells.
    Tripathi MK; Misra S; Chaudhuri G
    Biochem Biophys Res Commun; 2005 Apr; 329(2):508-15. PubMed ID: 15737616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
    Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
    Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells.
    Lambertini E; Lolli A; Vezzali F; Penolazzi L; Gambari R; Piva R
    BMC Cancer; 2012 Oct; 12():445. PubMed ID: 23031797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a transcriptional silencer upstream of the human BRCA2 gene.
    Sharan C; Hamilton NM; Parl AK; Singh PK; Chaudhuri G
    Biochem Biophys Res Commun; 1999 Nov; 265(2):285-90. PubMed ID: 10558858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
    Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function.
    Natesampillai S; Fernandez-Zapico ME; Urrutia R; Veldhuis JD
    J Biol Chem; 2006 Feb; 281(6):3040-7. PubMed ID: 16303770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG.
    Bailey CK; Mittal MK; Misra S; Chaudhuri G
    J Biol Chem; 2012 Jun; 287(23):19472-86. PubMed ID: 22496452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERalpha suppresses slug expression directly by transcriptional repression.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Barsky SH
    Biochem J; 2008 Dec; 416(2):179-87. PubMed ID: 18588516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.